.Attributes Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view asks for incorporation of people with MASLD and dimension of liver results in cardio-- kidney-- metabolic trials, when information recommend mechanistically tenable perks and also clinical safety and security-- and describes factors to consider for trial layout and also governing commendation.